New study links prenatal chemical exposure to childhood obesity trajectories

Connections between prenatal exposure to endocrine-disrupting chemicals and the growth patterns of children’s BMI.

A small group of melanoma patients may need far less immunotherapy with surgery, study suggests

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 3, 2024

First medicine developed to treat MASH expected to be approved soon

The Food and Drug Administration is expected to approve the first medicine developed specifically to treat the serious liver disease known as MASH as soon

March 12, 2024

Biophytis Announces $3.8 Million Registered Direct Offering – Biotech Investments

Biophytis / Key word(s): Financing Biophytis Announces $3.8 Million Registered Direct Offering 19-Jul-2023 / 07:53 CET/CEST Biophytis Announces $3.8 Million Registered Direct Offering

July 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.